Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)

Introduction: Enzymatic debridement for mixed depth and full thickness burns is gaining recognition as an important technique available to the burns surgeon. Reductions in blood loss, the need for autologous skin grafting and the number of wounds requiring surgical excision are among the benefits of...

Full description

Bibliographic Details
Main Authors: Neil Wickham, K. Skaria Alexander, Anthony Fletcher, Ciaran O’Boyle
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Scars, Burns & Healing
Online Access:https://doi.org/10.1177/2059513118821563
_version_ 1819104695080189952
author Neil Wickham
K. Skaria Alexander
Anthony Fletcher
Ciaran O’Boyle
author_facet Neil Wickham
K. Skaria Alexander
Anthony Fletcher
Ciaran O’Boyle
author_sort Neil Wickham
collection DOAJ
description Introduction: Enzymatic debridement for mixed depth and full thickness burns is gaining recognition as an important technique available to the burns surgeon. Reductions in blood loss, the need for autologous skin grafting and the number of wounds requiring surgical excision are among the benefits of this evolving treatment modality. We present a case of successful treatment using enzymatic debridement of mixed depth flame burns in a young patient with systemic sclerosis (scleroderma). Methods: A 24-year-old man with rapidly progressive limited cutaneous systemic sclerosis suffered approximately 6% mixed depth flame burns to the right leg including areas of likely deep partial thickness burn totalling approximately 2% total body surface area (TBSA). Enzymatic debridement using Nexobrid™ was performed under spinal anaesthesia in accordance with unit protocol. Pain was well controlled and at 4 h the Nexobrid™ was removed and replaced with saline-soaked gauze initially then simple dressings. After liaison with Rheumatology, he was also started on iloprost infusions over five days. He was discharged home on day 9 and completely healed by day 31. Scarring was minimal, the skin was soft and full, and pain-free range of movement of the right knee was maintained. Discussion and Conclusion: This case demonstrates the safety and effectiveness of enzymatic debridement of mixed depth burns in a patient with very compromised wound healing. Enzymatic debridement combined with iloprost infusion provided maximum preservation of viable dermis. The authors recommend that this treatment strategy is considered in similar cases.
first_indexed 2024-12-22T02:10:26Z
format Article
id doaj.art-b2228bdc6f1c4a0e99478a0931a1bd4b
institution Directory Open Access Journal
issn 2059-5131
language English
last_indexed 2024-12-22T02:10:26Z
publishDate 2019-01-01
publisher SAGE Publishing
record_format Article
series Scars, Burns & Healing
spelling doaj.art-b2228bdc6f1c4a0e99478a0931a1bd4b2022-12-21T18:42:26ZengSAGE PublishingScars, Burns & Healing2059-51312019-01-01510.1177/2059513118821563Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)Neil WickhamK. Skaria AlexanderAnthony FletcherCiaran O’BoyleIntroduction: Enzymatic debridement for mixed depth and full thickness burns is gaining recognition as an important technique available to the burns surgeon. Reductions in blood loss, the need for autologous skin grafting and the number of wounds requiring surgical excision are among the benefits of this evolving treatment modality. We present a case of successful treatment using enzymatic debridement of mixed depth flame burns in a young patient with systemic sclerosis (scleroderma). Methods: A 24-year-old man with rapidly progressive limited cutaneous systemic sclerosis suffered approximately 6% mixed depth flame burns to the right leg including areas of likely deep partial thickness burn totalling approximately 2% total body surface area (TBSA). Enzymatic debridement using Nexobrid™ was performed under spinal anaesthesia in accordance with unit protocol. Pain was well controlled and at 4 h the Nexobrid™ was removed and replaced with saline-soaked gauze initially then simple dressings. After liaison with Rheumatology, he was also started on iloprost infusions over five days. He was discharged home on day 9 and completely healed by day 31. Scarring was minimal, the skin was soft and full, and pain-free range of movement of the right knee was maintained. Discussion and Conclusion: This case demonstrates the safety and effectiveness of enzymatic debridement of mixed depth burns in a patient with very compromised wound healing. Enzymatic debridement combined with iloprost infusion provided maximum preservation of viable dermis. The authors recommend that this treatment strategy is considered in similar cases.https://doi.org/10.1177/2059513118821563
spellingShingle Neil Wickham
K. Skaria Alexander
Anthony Fletcher
Ciaran O’Boyle
Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
Scars, Burns & Healing
title Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
title_full Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
title_fullStr Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
title_full_unstemmed Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
title_short Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
title_sort successful treatment of mixed depth flame burns using enzymatic debridement with nexobrid™ in a patient with aggressive systemic sclerosis scleroderma
url https://doi.org/10.1177/2059513118821563
work_keys_str_mv AT neilwickham successfultreatmentofmixeddepthflameburnsusingenzymaticdebridementwithnexobridinapatientwithaggressivesystemicsclerosisscleroderma
AT kskariaalexander successfultreatmentofmixeddepthflameburnsusingenzymaticdebridementwithnexobridinapatientwithaggressivesystemicsclerosisscleroderma
AT anthonyfletcher successfultreatmentofmixeddepthflameburnsusingenzymaticdebridementwithnexobridinapatientwithaggressivesystemicsclerosisscleroderma
AT ciaranoboyle successfultreatmentofmixeddepthflameburnsusingenzymaticdebridementwithnexobridinapatientwithaggressivesystemicsclerosisscleroderma